论文部分内容阅读
目的:探讨紫衫醇联合顺铂治疗晚期食道癌的临床效果。方法:选取我院自2013年6月-2014年6月间收治的晚期食道癌患者78例作为研究对象,按照随机分配的原则将其分成两组,即对照组患者39例采用氟尿嘧啶联合顺铂化疗治疗,观察组患者39例采用紫杉醇联合顺铂进行化疗治疗,对比两组患者的治疗效果。结果:观察组患者的治疗总有效率和安全性均明显优于对照组,两组数据对比差异具有统计学意义,P<0.05。结论:在治疗晚期啊食道癌时采用紫杉醇联合顺铂能够显著提升治疗效果,因此非常值得临床上推广使用。
Objective: To investigate the clinical effect of paclitaxel plus cisplatin in the treatment of advanced esophageal cancer. Methods: Seventy-eight patients with advanced esophageal cancer who were treated in our hospital from June 2013 to June 2014 were selected as the research objects. They were divided into two groups according to the principle of random distribution: 39 patients in the control group received fluorouracil and cisplatin Chemotherapy, the observation group of 39 patients treated with paclitaxel combined with cisplatin chemotherapy, the treatment of two groups were compared. Results: The total effective rate and safety of the observation group were significantly better than that of the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: The treatment of advanced esophageal cancer with paclitaxel combined with cisplatin can significantly improve the therapeutic effect, it is worth to promote the clinical use.